Disease Info Card

Bronchogenic Carcinoma

Information about Bronchogenic Carcinoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Bronchogenic Carcinoma

Most recent studies have shown that Bronchogenic Carcinoma shares some biological mechanisms with adenocarcinoma, brain-neoplasms, bronchial-neoplasms, carcinoma, lung-diseases, lung-neoplasms, lymphatic-metastasis, malignant-neoplasm-of-lung, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-squamous-cell-neoplasm, mammary-neoplasms, neoplasm-metastasis, neoplasm-of-uncertain-or-unknown-behavior-of-mediastinum, neoplasms, non-small-cell-lung-carcinoma, pneumonia, small-cell-carcinoma-of-lung, tuberculosis, tuberculosis-pulmonary.

Among the many pathways, these few ones have gauged particular interests from scientists studying Bronchogenic Carcinoma, and have been seen in publications frequently: Aging, Angiogenesis, Cell Cycle, Cell Differentiation, Cell Growth, Cell Proliferation, Chemotaxis, Coagulation, Dehiscence, Dna Repair, Excretion, Hormone Secretion, Hypersensitivity, Immune Response, Inflammatory Response, Keratinization, Localization, Pathogenesis, Secretion, Transport

Quite a number of genes have been found to play important roles in Bronchogenic Carcinoma, such as ACAT1, ALB, AVP, CALCA, CEACAM5, CEACAM7, EGFR, ENO1, ENO2, IL2, OAT, POMC, PSG2, SLC25A5, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.